Status:
UNKNOWN
Therapeutic Effect of Blood Flow Reconstruction in IVADA
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Intracranial Aneurysm
Eligibility:
All Genders
30-80 years
Brief Summary
IVADA (Intracranial vertebral artery dissecting aneurysms）is one of the causes of subarachnoid hemorrhage or posterior circulation ischemia with high mortality and disability. Current endovascular the...
Detailed Description
This is a single-center, retrospective, and observational study.This retrospective study was approved by the Medical Ethics Committee of Qilu Hospital of Shandong University.Patients diagnosed with IV...
Eligibility Criteria
Inclusion
- Patients with asymptomatic or SAH symptoms of intracranial hypertension
- After a preliminary diagnosis of cerebrovascular CTA or MRA, DSA angiography confirmed IVADA
- IVADA involves intracranial segment of vertebral artery (V4 )
Exclusion
- : Patients with SAH caused by trauma or other cerebrovascular diseases
- 2: IVADA involves the extracranial vertebral artery
- 3: Vertebrobasilar artery tortuosity and dilatation
Key Trial Info
Start Date :
December 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06134557
Start Date
December 20 2023
End Date
February 28 2024
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, China